M. Michelle Berrey's Insider Trades & SAST Disclosures
M. Michelle Berrey's most recent trade in Intercept Pharmaceuticals Inc was a trade of 1,246 Common Stock done at an average price of $12.0 . Disclosure was reported to the exchange on June 14, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern M. Michelle Berrey.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intercept Pharmaceuticals Inc | Michelle Berrey | President, R&D & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.04 per share. | 14 Jun 2023 | 1,246 | 81,385 (0%) | 0% | 12.0 | 15,002 | Common Stock |
| Intercept Pharmaceuticals Inc | Michelle Berrey | President, R&D & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.79 per share. | 14 Mar 2023 | 1,246 | 82,631 (0%) | 0% | 15.8 | 19,674 | Common Stock |
| Ocean Biomedical Inc. | Michelle Berrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Intercept Pharmaceuticals Inc | Michelle Berrey | President, R&D & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 24,000 | 24,000 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Michelle Berrey | President, R&D & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 14,700 | 83,877 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Michelle Berrey | President, R&D & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. | 31 Dec 2022 | 765 | 69,177 (0%) | 0% | 12.4 | 9,463 | Common Stock |
| Intercept Pharmaceuticals Inc | Michelle Berrey | President, R&D and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.94 per share. | 14 Dec 2022 | 1,246 | 69,942 (0%) | 0% | 14.9 | 18,615 | Common Stock |
| Intercept Pharmaceuticals Inc | Michelle Berrey | President, R&D and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.14 per share. | 14 Sep 2022 | 1,246 | 71,188 (0%) | 0% | 17.1 | 21,356 | Common Stock |
| Intercept Pharmaceuticals Inc | Michelle Berrey | President, R&D and CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.10 per share. | 14 Jun 2022 | 4,984 | 72,434 (0%) | 0% | 12.1 | 60,306 | Common Stock |
| Intercept Pharmaceuticals Inc | Michelle Berrey | President, R&D and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 17,600 | 17,600 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Michelle Berrey | President, R&D and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 10,300 | 77,418 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges